Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
RVL Pharmaceuticals plc - Ordinary Shares
(NQ:
RVLP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RVL Pharmaceuticals plc - Ordinary Shares
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 20, 2023
Via
Benzinga
Earnings Outlook For RVL Pharmaceuticals plc - Ordinary Shares
March 17, 2023
Via
Benzinga
RVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed Overview
December 21, 2022
Via
Benzinga
Earnings Scheduled For November 10, 2022
November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Netflix To Rally Around 17%? Plus This Analyst Predicts $144 For Electronic Arts
October 25, 2022
Daiwa Capital boosted the price target on Netflix, Inc. (NASDAQ: NFLX) from $226 to $330. Daiwa Capital analyst Satoshi Tanaka upgraded the stock from Neutral to Outperform. Netflix shares fell 2.5% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 19, 2022
Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 19, 2022
Good morning, investors! We're starting off Wednesday with a breakdown of the biggest pre-market stock movers this morning!
Via
InvestorPlace
RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment
July 08, 2022
Via
Benzinga
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
September 26, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 23, 2022
Gainers
Via
Benzinga
7 Stocks to Sell Now
July 19, 2022
Not all stocks will benefit even if the markets turn around. These stocks to sell are likely to keep going lower, rather than rebounding.
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
September 15, 2022
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.
Via
Benzinga
RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
May 11, 2022
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.
Via
Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
September 14, 2022
Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.
Via
Benzinga
RVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed Insights
March 31, 2022
Benzinga Pro data, RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) reported Q4 sales of $2.86 million. Earnings fell to a loss of $19.72 million, resulting in a 10.43% decrease from last...
Via
Benzinga
RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
March 29, 2022
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement.
Via
Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via
Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
August 15, 2022
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 18, 2022
Gainers
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
Earnings Scheduled For March 30, 2022
March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 24, 2022
Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.